Glucocorticoid Clinical Trials

2 recruiting

Glucocorticoid Trials at a Glance

10 actively recruiting trials for glucocorticoid are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 4 with 4 trials, with the heaviest enrollment activity in Changchun, Changzhou, and Chengdu. Lead sponsors running glucocorticoid studies include Assistance Publique - Hôpitaux de Paris, Associate Professor Morton Burt, and Amgen.

Browse glucocorticoid trials by phase

Treatments under study

About Glucocorticoid Clinical Trials

Looking for clinical trials for Glucocorticoid? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glucocorticoid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glucocorticoid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Glucocorticoid-induced Osteoporosis
Amgen100 enrolled16 locationsNCT06588153
Recruiting
Phase 2Phase 3

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

Lung Cancer (NSCLC)AnalgeticVideo Assisted Thoracic Surgery (VATS)+1 more
Rigshospitalet, Denmark80 enrolled1 locationNCT07213375
Recruiting
Not Applicable

Efficacy and Safety of Telitacicept in IgAN

GlucocorticoidKidney DiseasesIgA Nephropathy (IgAN)+1 more
Ruijin Hospital118 enrolled1 locationNCT06654596
Recruiting
Phase 4

Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study

OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050
Recruiting
Phase 4

Diesel Exhaust Induces Glucocorticoid Resistance

Exposure to PollutionGlucocorticoid Resistance
University of British Columbia30 enrolled1 locationNCT03615742
Recruiting
Phase 4

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Immune ThrombocytopeniaChild, OnlyGlucocorticoids
Fujian Medical University Union Hospital608 enrolled1 locationNCT05522465
Recruiting
Not Applicable

Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)

Adult Glucocorticoid ExcessAdult Adrenal Insufficiency
Assistance Publique - Hôpitaux de Paris540 enrolled1 locationNCT04840693
Recruiting
Phase 2

Can Mineralocorticoid Receptor Antagonism Counteract Cardiometabolic Long-term Effects of Steroids? (MiRACCLES study)

Cardiometabolic complications of excess glucocorticoid exposure
Dr Moe Thuzar60 enrolled1 locationACTRN12622000671763
Recruiting

Optimum Diagnostic Testing for Glucocorticoid Induced Hyperglycaemia

Diabetes induced by Glucocorticoids
Associate Professor Morton Burt100 enrolled3 locationsACTRN12621001106820
Recruiting
Phase 2Phase 3

Treatment of glucocorticoid-induced protein wasting

Long-term glucocorticoid users with polymyalgia rheumatica
St Vincent's Hospital24 enrolled1 locationACTRN12605000642684